East Carolina University. Tomorrow starts here.®
 




 


Harland,-Robert_web

 

 

Robert Carl Harland, M.D., FACS
Chief of Surgical Immunology and Transplantation

 

Address
Department of Surgery
Brody School of Medicine
East Carolina University
639 Moye Boulevard
Greenville, NC 27834
252-744-2620 (office)
HarlandR@ecu.edu

Education
1975-1979    B.S.    Chemistry, Biology Whitworth College, Spokane, Washington
1979-1983    M.D.    Duke  University  School  of  Medicine,  Durham,  North Carolina

Postgraduate Training
1983-1985    Department of Medicine, Duke University Medical Center
Internship, Junior Assistant Resident

1985-1986    Department of Surgery, Duke University Medical Center
Junior Assistant Resident

1986-1986    Department of Medicine, Duke University Medical Center
Senior Assistant Resident

1987-1988    Department of Surgery, Duke University Medical Center
Research Fellow

1989-1991    Department of Surgery, Duke University Medical Center
Senior Assistant Resident

1991-1992    Department of Surgery, Duke University Medical Center
Chief Resident

1992-1994    Department of Surgery, Duke University Medical Center
Fellow in Transplantation

Research Training
1977-1980      Department of Pharmacology, University of Oregon Health
Sciences Center, Portland, Oregon
Under direction of: Nicholas Gerber, M.D.
Title:  "Pharmacokinetics of anti-convulsants"

1981-1982    Immunology Study Program, Duke University School of
Medicine, Durham, North Carolina
Title:  "Repopulation of lymphocytes following syngeneic and allogeneic bone marrow transplantation"

1987-1989    D. Bernard Amos Transplantation Immunology
Laboratory, Department of Surgery, Duke University
Medical Center, Durham, North Carolina
Under direction of:  R. Randall Bollinger, M.D., Ph.D.

Hospital Appointments
1993-1999    Chief, Transplant Surgery, Durham VA
Medical Center, Durham, NC

1994-1999    Director, Renal Transplant Program
Director, Pancreas Transplant Program, Duke University Medical Center, Durham, NC

1999-2001    Chief, Transplantation Surgery
University of Massachusetts Medical Center, Worcester, MA

2001-2010     Director, Renal Transplant Program                                           
Director, Pancreas Transplant Program

University of Chicago Medical Center, Chicago, IL

2009-2010     Director, Multi-Organ Transplant Fellowship Program                        University of Chicago Medical Center, Chicago, IL

2009-2010     Director, Transplant Outreach and Satellite Programs                                
University of Chicago Medical Center, Chicago, IL


 
Medical School Appointments
1992-1999    Assistant Professor
Department of Surgery, Duke University, Durham, NC

1993-1999    Assistant Clinical Professor of Surgery,
University of North Carolina School of Medicine, Chapel Hill, NC

1999- 2001    Professor
Department of Surgery
Residency Program Director
University of Massachusetts School of Medicine, Worcester, MA

2000-2001    Associate Professor
Department of Medicine
University of Massachusetts Medical School, Worcester MA

2001-2009    Associate Professor of Surgery and Medicine
University of Chicago/Pritzker School of Medicine, Chicago, IL

Licensing Examinations
1980-1984    NBME
Part 1    9/3/1980    Passed
Part 2    9/22/1981    Passed
Part 3    3/7/1984    Passed

Board Certification
1987    Diplomate, American Board of Internal Medicine
1993    Diplomate, American Board of Surgery
1994    ASTS Certified Multi-Organ Transplant Surgery Fellowship
2003    Recertification, American Board of Surgery

Medical Licensure

1989    North Carolina Medical Licensure
1999    Massachusetts Medical Licensure
2001    Illinois Medical Licensure

Activities in Organizations
1995-1999    Institutional Director, Southeastern Organ Procurement Foundation

1995-1997    Co-Chair, Scientific Affairs Committee, Southeastern Organ
Procurement Foundation

1995-1997    Vice President, Carolina Organ Procurement Agency

1997-2010    Alternate Institutional Representative, United Network for Organ
Sharing

1997-1999    President, Carolina Organ Procurement Agency

2001-2010    Medical Advisory Board Member,
Kidney Transplant Committee Member, (chair 2004-2005) Pancreas Transplant Committee Member, (chair 2008-2009) Gift of Hope Organ and Tissue Donor Network

2003-2007    Member, Patient Education Committee, American Society of
Transplantation

2005-2007    Team Leader, Gift 4 Hope, National Organ Transplant Breakthrough
Collaborative, UNOS and HHS

2007-2010   National Kidney Foundation-IL
Member, Medical Advisory Board

2008-2010  Member, ECD and DCD Task Forces
Gift of Hope Organ and Tissue Donor Network

Grant Review Committees
1999-2004    Merit Review-Surgery, Department of Veteran’s Affairs
Chairman: 2004

Invited Journal Reviewer
American Journal of Transplantation
Journal of Urology
Journal of Gastrointestinal Surgery
Urology
Xenotransplantation

Professional Memberships
Fellow, American College of Surgeons
Member, American Society of Transplant Surgeons Member, Association for Academic Surgery
Member, Society for Surgery of the Alimentary Tract Member, North Carolina Medical Society
Member, North Carolina Medical Society
Member, The Transplantation Society
Member, International Pancreas and Islet Transplantation Association
Member, International Xenotransplant Society
Member, New England Surgical Society
Member, Illinois Surgical Society

Committee Memberships
DUKE UNIVERSITY SCHOOL OF MEDICINE/ MEDICAL CENTER
1994-1999    Chair, Committee on Organ and Tissue Donation
1996-1999    Clinical Research Center Scientific Advisory Board

UNIVERSITY OF MASSACHUSETTS/ UMASS MEMORIAL HEALTH CARE
1999-2001    Clinical Product Standardization Committee
1999-2001    Graduate Medical Education Committee
1999-2001    Co-Chair, Operating Room Committee
1999-2001    Organ and Tissue Donation Committee
1999-2000    Supply Chain Improvement Committee
1999-2000    Co-Chair, Graduate Medical Education Mission Workshop
1999-2001    UMass Memorial Benefits Subcommittee
1999-2001    Advisory Committee Macy Initiative, Health Communication
2000-2001    Surgery Chair Search Committee

THE UNIVERSITY OF CHICAGO
2005-2008    Co-chair, Physician Advisory Group, Achieving Breakthroughs
Initiative
2005-2009   Surgery Resident Education Committee
2007-2009    Ambulatory MD Workgroup - Phoenix Project  (EMR development)
2007-2009    Surgical Quality Subcommittee member
2008-2009    Medical Staff nominating committee member
2008-2009    Co-chair, Transplant Center Strategic Planning Committee

Extramural Awards
1993-1995    Principal Investigator, American Heart Association, North  Carolina Affiliate
Research Award, Mechanisms of Accommodation in Xenotransplantation

1994-1999    Co-Principal Investigator, PO-1 NHLB1, Barriers to Xenotransplantation

1997-1999    Principal Investigator
Abbott Pharmaceuticals
A multicenter randomized, placebo controlled trial of ANTILFA in the prevention of delayed graft function in kidney transplant recipients

1997-1998    Co-Investigator
Novartis Pharmaceuticals
A multicenter, randomized, double-blind placebo controlled trial of Simulect in denovo liver transplant recipients.

1997-2000    Principal Investigator
CCTC/Steroid Withdrawal Study Group
A prospective, randomized trial of steroid withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil

1998-1999    Co-Investigator
Novartis Pharmaceuticals
A one-year, multicenter, randomized, placebo-controlled, double-blind, parallel
group, dose-finding study to evaluate the safety, tolerability, and pharmacokinetics of SDZ RAD in de novo liver transplant recipients

2001-2004    Principal Investigator
Roche Pharmaceuticals
An open label comparative trial of two Daclizumab dosing strategies versus no
induction treatment in combination with Tacrolimus, Mycophenolate Mofetil, and Steroids for the prevention of acute allograft rejection in simultaneous
Kidney/Pancreas transplant recipients

2004-2010   Principal Investigator
Astellas Pharmaceuticals
A Phase III, randomized, open-label, comparative multi-center study to assess the
safety and efficacy of Prograf (tacrolimus)/MMF, modified release (MR)
tacrolimus/MMF and Neoral (cyclosporine)/MMF in de novo kidney transplant
recipients

2004-2010    Principal Investigator
Astellas Pharmaceuticals
A phase II, randomized, open-label, parallel group, multi-center study to assess the
safety and efficacy of Prograf/FK778 and Prograf/MMF in de novo kidney
transplant recipients

2004-2010   Principal Investigator
UCSF/NIH
Solid organ transplantation in HIV:  multi-site study

2005-2010    Principal Investigator
Roche Pharmaceuticals
An open label prospective, randomized, controlled, multi-center study assessing fixed dose vs. concentration controlled CellCept regimens for patients following a single organ renal transplantation in combination with full dose and reduced dose calcineurin inhibitors

2006-2010   Principal Investigator
Isotechnika, Inc.
A phase IIB, randomized, multicenter, open-label, concentration-controlled, safety
study of ISA247 and tacrolimus (Prograf) in de novo renal transplant patients
(ISA05-01)

2007-2010  Principal Investigator
    Pfizer
A Phase II randomized, multicenter, active comparator-controlled trial to evaluate the safety and efficacy of coadministration of CP-690,550 and mycophenolate mofetil/mycophenolate sodium in DeNovo kidney allograft recipients.

2008-2010  Principal Investigator
Astellas Pharmaceuticals
A Phase II, randomized, open-label, parallel group, multi-center study to assess the safety and efficacy of alefacept in DeNovo kidney transplant recipients.

Honors and Awards
Undergraduate
1979    Phi Alpha (academic honor society)
1979    Outstanding Chemistry Graduate Award

Medical School
1981    Alpha Omega Alpha
Strickland Scholarship (4 years)

Residency
1992    Golden Apple Teaching Award

Faculty
1997    Davison Society Excellence in Teaching Award
1997    David C. Sabiston, Jr. Award for Excellence in Resident Education
2005    Robert Baker Golden Apple Teaching Award


Undergraduate Lectures
Winter 2003    University of Chicago
Organ Transplantation Course #25405
Organ Procurement and Allocation
Kidney Transplantation

Winter 2005    University of Chicago
Organ Transplantation Course #25407
Organ Matching and Allocation
Kidney Transplantation

9/02/2005    Illinois Institute of Technology
Biomedical Engineering Course
Vascular Disease in Diabetics: Between a rock and a hard place

Winter 2007    University of Chicago
Organ Transplantation Course #25410
Organ Matching and Allocation
Kidney Transplantation

Winter 2009    University of Chicago
Organ Transplant Course #25410
Kidney Transplantation

Medical School and Residency Programs Lectures
Anesthesiology

10/19/2001 Perioperative Care of the Transplant Patient
8/28/2003  Perioperative Care of the Transplant Patient
7/11/2005  Perioperative Care of the Transplant Patient
7/19/2007  Perioperative Care of the Transplant Patient
8/19/2008  Perioperative Care of the Transplant Patient

Pediatrics
3/04/2004 Grand Rounds: Pediatric Kidney Transplantation

Surgery
9/19/2001 Grand Rounds:  Current Trends in Renal Transplantation
4/14/2004 Grand Rounds:  Geriatric Kidney Transplantation
10/05/2005 Grand Rounds:  Transplant Immunology and Transplant Rejection/Immunosuppression

Local Outreach Efforts
9/02/2003 Southwest Nephrology Associates
“Transplant Immunosuppression:  Current Trends”

4/13/2004 Nephrology Associates of NW Indiana
“Current Trends in Transplant Immunosuppression”

10/28/2005 Nephrology Associates of NW Indiana
“Long-term Management of Immunosuppression”

1/22/2009 St. Anthony  Medical Center, Crown Point, Indiana
“Options for Dialysis Access and Transplantation”

4/17/2009 OptumHealth SNAPSHOT
“Renal Dysfunction and Multi-organ Transplantation”

5/2/2009 Lupus Foundation of America-Indiana Chapter
“Kidney Disease and Transplantation”

Invited Regional and National Lectures
2/1998    Invited Speaker
Southeast Organ Procurement Foundation Tri-annual Meeting
“Barriers to Successful Xenotransplantation”

5/1998    Invited Speaker
Southeast Organ Procurement Foundation Tri-annual Meeting
“Xenotransplantation”

10/1999    Visiting Professor
Berkshire Medical Center, Pittsfield, Massachusetts Department of Surgery
“Pancreas Transplantation - 2000”
“Dialysis Access:  Problems and Solutions”
“Expanding the Organ Donor Pool”

11/1999    Invited Speaker
Southeast Dialysis and Transplant Association Annual Meeting,
    New Orleans
“The Future:  Xenotransplantation”

11/12/1999    Invited Lecturer
Metrowest Medical Center, Framingham, Massachusetts
Department of Surgery Grand Rounds
“Pancreas Transplantation for Diabetes”

2/02/2000    Invited Lecturer
New England Medical Center, Boston, Massachusetts
Department of Surgery
“Pancreas Transplant Update”

4/04/2000    Invited Lecturer
Beth Israel/Deaconess Medical Center, Boston, Mass.
Transplant Lecture Series
“Pancreas Transplantation - 2000”

2/18/2001    Invited Speaker
National Kidney Foundation-Illinois Chapter
“Steroid sparing regimens in transplantation”

5/18/2001    Invited Speaker
Transplant 2001-Annual Meeting of AST/ASTS
“Hand-assisted Laparoscopic Donor Nephrectomy”

3/11/2002    Invited Speaker
Organ Transplant Support-Illinois
“What’s New in Kidney Transplantation?”

4/13/2002    Invited Speaker
NKF-Illinois, Living with Transplant
“Living Happily Ever After With Your Transplant”

5/02/2002    Invited Speaker
UNOS Region 7 Tri-annual Transplant Forum
“Expanding Donor Options for Kidney Transplantation”

9/22/2002    Invited Speaker
United Resource Network Annual Conference
“Increasing the Kidney Donor Pool”

7/23/2003    Invited Speaker
Roche National Transplant Group Quarterly Meeting
“BK Polyomavirus in Transplantation”

8/28/2003    Invited Speaker
Southeast Organ Procurement Foundation Tri-annual Meeting
“BK Polyomavirus in Transplantation”

4/21/2004    Invited Speaker
UNOS Region 7 Tri-annual Transplant Forum
“The Challenge of Transplanting the Sensitized Recipient”

4/01/2004    Invited Speaker
Accredo Therapeutics National Sales Meeting
“IVIG in Solid Organ Transplantation”

5/01/2004    Invited Speaker
Cigna National Transplant conference
“Transplantation for HIV+ Patients”

11/11/2004    Invited Speaker
Kaiser Transplant Network
“What’s New in Pancreas transplantation”

4/09/2005    Invited Speaker
NKF-Illinois, Living with Transplant
“State of Transplantation: 2005”

11/02/2005    Invited Speaker
Gift of Hope Procurement Forum
“Sharing of Vessels for Extrarenal Organ Transplantation“

2/07/2006    Invited Keynote Speaker
Leadership Development Institute
University of Chicago Academy
“Teamwork: A Formula for Success”

8/25/2006    Invited Speaker and Workshop Leader
NATCO Annual meeting
“Recovery Techniques and Anatomy”

10/20/2007    Invited Speaker
American Academy of Pediatrics National Conference & Exhibition
“Pancreas Transplantation in 2007”

2/11/2008    Invited Speaker
American Society for Parenteral and Enteral Nutrition
(ASPEN) Annual meeting
“Renal Dysfunction after solid organ transplantation”

4/6/2009    Invited Speaker
Surgery Grand Rounds
Hahnemann/Drexel University
“Donor Transmitted Disease in Transplantation”

4/30/2009    Invited Speaker
UNOS Region 7 Spring Collaborative Learning Session
“Dual Kidney Transplantation”

5/5/2009    Invited Speaker
National Transplant Network Annual Clinical Update
Kaiser Permanente
“Type 1.5 diabetes: The changing spectrum of Diabetes”

Bibliography

Original Reports

1.     Dickinson RG, Harland RC, Rodgers RM, Gordon WP, Lynn RK, Gerber N. Dose dependent
metabolism and enterohepatic recirculation of valproic acid in the rat.  Proceedings of the Western Pharmacological Society, 1978;21:217-220.

2.    Swanson BN, Harland RC, Dickinson RG, Gerber N.  Excretion of valproic acid into semen
of rabbits and man.  Epilepsia. 1978;19(6):541-546.

3.     Gerber N, Dickinson RG, Harland RC, Lynn RK, Houghton D, Antonias JI, Schimschock JC.
Reye-like syndrome associated with valproic acid therapy. J Pediatrics. 1979;94:824-827.

4.     Dickinson RG, Harland RC, Lynn RK, Smith WB and Gerber N.  Transmission of valproic
acid (Depakene) across the placenta:  half-life of the drug in mother and baby.  J Pediatrics. 1979;95:142-144.

5.     Dickinson RG, Harland RC, Ilias AM, Rodgers RM, Kaufman SN, Lynn RK, Gerber N.
Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic
recirculation and choleretic effect.  J Pharmacol & Exp Therapeutics 1979;211(3):583-95.

6.     Dickinson RG, Harland RC, Kaufman SN, Lynn RK, Gerber N.  An osmotic explanation for
valproic acid induced choleresis in the rat, dog and monkey.  Arzneimittel-Forschung 1982;32(3):241-7.

7.     Yamaguchi Y, Harland RC, Bollinger RR.  Prolonged survival of hepatic xenografts in the
hamster to rat combination: efficacy of cyclosporine in combination with splenectomy. Transplantation Proceedings 1988;20(1 Suppl 1):731-3.

8.     Bollinger RR, Yamaguchi Y, Harland RC, Wyble C, Mori K.  Effects of donor splenocytes
treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.  Transplantation Proceedings 1989;21(1 Pt 1):213-4.

9.     Ruiz P, R.C. Harland, Yamaguchi Y, Bollinger RR, Sanfilippo F.  In situ and systemic cellular
immunity associated with orthotopic rat liver allograft acceptance or rejection. Transplantation Proceedings 1989;21(1 Pt 1):416-20.

10.     Yamaguchi Y, Harland RC, Wyble C, Bollinger RR.  The role of RT1.a major
histocompatibility antigens in prolonging the survival of hepatic allografts in the rat. Transplantation Proceedings 1989;21(1 Pt 1):792-3.

11.     Harland RC, Halperin EC, Yamaguchi Y, Ruiz P, Scroggs MW, Sanfilippo F,  Bollinger RR.
Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model.  Transplantation Proceedings 1989;21(1 Pt 1):1118-9.

12.     Yamaguchi Y, Harland RC, Wyble C, Bollinger RR. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. Transplantation 1989;47(1):171-7.

13.     Yamaguchi Y., Harland RC, Wyble C, Mori K, Bollinger RR.  Variable allograft responses to
pretreatment with donor splenocytes treated with mitomycin C in the rat.  Transplantation 1989;47(2):360-3.

14.     Ruiz P, Harland RC, Fuller J, Yamaguchi Y, Bollinger RR, Sanfilippo F.  Characteristics of
alloreactive rat T cell lines established from low and high rejecting orthotopic liver transplants. Transplantation Proceedings 1989;21(2):3286-3288.

15.     Yamaguchi Y, Harland RC, Wyble C, Bollinger RR.  The effect of pretreatment with class I
major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.  Transplantation Proceedings 1989;21(3):3555.

16.     Yamaguchi Y, Halperin EC, Harland RC, Wyble C, Bollinger RR. A synergistic effect of total
lymphoid irradiation, cyclosporine and splenectomy in a hamster-to-rat hepatic xenograft model.  Transplantation Proceeding 1989;21(3):3556.

17.     Knechtle SJ, YamaguchiY, Harland RC, CoundouriotisA, Bollinger RR.  The role of class I
antigens in hyperacute rejection of hepatic allografts in rats.  Transplant Proceedings 1989;21(3):3557.

18.     Bollinger RR, Knechtle SJ, Harland RC, Yamaguchi Y,  Halperin EC.  New approaches to
immunosuppression for xenotransplantation.  In:  Hardy M, ed. Xenograft 25.  Elsevier Science Publishers, 1989:45-54.

19.     Halperin EC, Knechtle SJ, Harland RC, Yamaguchi Y, Sontag M, Bollinger RR. Irradiation
for xenogeneic transplantation.  Radiotherapy & Oncology 1990;18(1):29-37.

20.     Yamaguchi Y, Halperin EC, Harland RC, Wyble C, Bollinger RR. Significant prolongation of
hamster liver transplant survival in Lewis rats by total lymphoid irradiation, cyclosporine and splenectomy.  Transplantation 1990;49(1):13-17.

21.     Bollinger RR, Fabian MA,  Harland RC,  Murray WJ, Baldwin WM, Abernethy K, Britt L,
Sontag M, Halperin EC.  Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates.  Transplantation Proceedings 1991;23(1 Pt 1):587-588.

22.     Bollinger RR, Fabian MA, Abernethy KA,  Harland RC, DeBuysscher EV,    Baldwin WM.
IgG is a prominent component of cynomolgus antiporcine natural xenoantibody. Transplantation Proceedings 1992;24(2):435.

23.     Chari RS, Collins BH, Magee JC, DiMaio JM, Kirk AD, Harland RC, McCann RL, Platt JL,
Meyers WC.  Brief report:  treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation.  N Engl J Med 1994 Jul 28;331(4):268-9.

24.     Collins BH, Chari RS, Magee JC, Harland RC, Lindman BJ, Logan JS, Bollinger RR, Meyers WC, Platt JL. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure.  Transplantation 1994;58(11):1162-1171.

25.    Harland RC.  Placement of permanent vascular access, surgical considerations. Advances in
Renal Replacement Therapy 1994; Jul 1(2):99-106.

26.     Harland RC, Vernon WB, Bunzendahl H, Thompson JK, Lawrence C, Bollinger RR.
Ganciclovir/Acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients.  Transplantation Proceedings 1994;26(2):432-3.

27.     Harland RC, Bollinger RR.  Extracorporeal hepatic perfusion in the treatment of patients with
acute hepatic failure.  Transplantation Reviews 1994; 8(2):73-79.

28.     Magee JC, Collins BH, Harland RC, Lindman BJ, Bollinger RR, Frank MM, Platt JL.
Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation.  J Clinical Investigation. 1995;96(3):2404-12.

29.     Liu K, Wigfall DR, Harland RC, Sanfilippo FP, Howell DN.  Identification of selective
immunoglobin A deficiency by renal biopsy.  Am J Kidney Diseases. 1995;26(3):520-526.

30.     Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL. The humoral immune response in
humans following crossperfusion of porcine organs.  Transplantation 1995;60(8):861-8.

31.     Collins BH, Chari RS, Magee JC, Harland RC, Lindman BJ, Logan JS, Bollinger RR, Meyers
WC, Platt JL. Immunopathology of porcine livers perfused with blood of humans with fulminant hepatic failure.  Transplantation Proceedings 1995;27(1):280-1.

32.     Harland RC, Logan JS, Kooyman D, Bryne GW, Platt JL. Ex vivo perfusion of mouse hearts
expressing the human complement regulatory protein CD59.  Transplantation Proceedings 1995;26(3):1245.

33.     Magee JC, Collins BH, Harland RC, Bollinger RR Frank MM, Platt JL.  Prevention of
hyperacute xenograft rejection by intravenous immunoglobulin.  Transplantation Proceedings 1995;27(1):271.

34.    Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL. The humoral immune response in
humans following ex vivo perfusion of porcine organs.  Transplantation Proceedings
1996;8(2):546.

35.    Suhocki PV, Lawson JH, Harland RC, Smith TP.  Curing a consumptive coagulopathy with
transcatheter embolization of a visceral artery aneurysm.  Am J Radiol 1996;166:982-984.

36.    Harland RC, Platt JL. Prospects for xenotransplantation of the liver.  J Hepatology.
1996;25(2):248-258.

37.     Broome AH, Eisen GM, Harland RC, Collins BH, Meyers WC, Pappas TN. Quality of life
after treatment for pancreatitis.  Ann Surg 1996;223(6): 665-672.

38.     Suhocki PV, Conlon PJ, Knelson MH, Harland RC, Schwab SJ.  Silastic cuffed catheters for
hemodialysis vascular access:  thrombolytic and mechanical correction of malfunction.  Am J Kidney Diseases  1996;28(3):379-86.

39.     Clavien PA, Sharara AI, Camargo CA Jr, Harland RC, Fitz JG. Evidence that ursodeoxycholic
acid prevents steroid-resistant rejection in adult liver transplantation.  Clinical Transplantation 1996;10:658-662.

40.     Lawson JH, Hoopes CW, Weidner BC, Davis RD, Harland RC, Diamond LE, Byrne G, Platt
JL. The role of transgenic expression of human complement regulatory proteins in discordant xenotransplantation.  Surgical Forum 1997;98:487-9.

41.    Yadav SS, Martin PD, Clavien PA, Harland RC. Comparison of techniques for rapid cooling
of organs in a non-heart-beating porcine model.  Transplantation Proceedings 1997;29:3559-
60.

42.     Yadav SS, Gao W, Harland RC, Clavien PA. A new and simple technique of total hepatic
ischemia in the mouse.  Transplantation 1998;65(11):1433-1436.

43.     Clavien PA, Selzner M, Tuttle-Newhall JE, Harland, Suhocki P. Liver transplantation
complicated by misplaced TIPS in the portal vein. Ann Surg 1998;227(3): 440-5.

44.     Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, Daniels LJ, Daggett
CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS, Platt JL.  The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.  J Clinical Investigation 1998;101(8): 1745-1756.

45.     Garfinkel MR, Harland RC, Opara EC.  Optimization of the microencapsulated islet for
transplantation.  J Surg Research 1998;76(1):7-10.

46.     Yadav SS, Howell DN, Steeber DA, Gao W, Harland RC, Tedder TF, Clavien PA.  L-selectin
and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver.  Am J Physiology 1998;275(6 Pt 1):G1341-52.

47.    Porte RJ, Tuttle-Newhall JE, Trotter JF, Harland RC, Clavien P-A.  Severe pneumonitis
associated with recurrent hepatitis C after liver transplantation. Hepatology 1998;28(4)Pt.
2:220A.

48.     Tuttle-Newhall JE, Rutledge RR, Clavien P-A, Harland RC.  Prediction of outcomes of liver
transplantation using the international classification of disease based injury severity score (ICISS) model.  Hepatology 1998;28(4)Pt. 2:769A.

49.     Smith SR, Butterly DW, Conlon PJ, Harland RC, Emovon OE.  Incidence of cytomegalovirus
disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary? Transplantation Proceedings 1998;130(5):2097-9.

50.    Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien P-A. P-Selectin
mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver.  Hepatology 1999;29:1494-1502.

51.     Foley DP, Collins BC, Magee JC, Platt JL, Katz E, Harland RC, Meyers WC, Chari RS.  Bile
acids in xenogeneic ex-vivo liver perfusion : Function of  xenoperfused livers and
compatibility with human bile salts and porcine livers.  Transplantation. 2000;69(2):242-8.

52.     Charles K, Harland RC, Ching D, Opara EC.  Storage and microencapsulation of islets for
transplantation.  Cell Transplantation 2000;9(1):33-8.

53.    Claytor RB, Li JM, Shah SA, Harland RC, Rohrer MJ.  Simvastatin induces apoptosis in
proliferating human saphenous vein endothelial cells through PARP cleavage, Surgical Forum.
October 2000

54.     Ching CD. Harland RC. Collins BH. Kendall W. Hobbs H. Opara EC. A Reliable Method for
Isolation of Viable Porcine Islet Cells.  Archives of Surgery 2001; 136(3):276-279.

55.     Kercher K, Dahl D, Harland R, Blute R, Gallagher K, Litwin D. Hand-assisted laparoscopic
donor nephrectomy minimizes warm ischemia.  Urology. 58(2):152-6, 2001.

56.     Banuelos SD, Turgeon N, Shultz L, Harland RC, Lyons B, Rossini AA, Greiner DL, Appel
MC. Hu-PBL-NOD-scid B2Mnull Mice Reject DR4 Transgenic NOD-scid Mouse Skin. Surgical Forum, October, 2001.

57.     Renal Tolerance to prolonged warm ischemia time in a laparoscopic versus open surgery
procine model.  Urology.  2004.  Volume 172, Issue 6, Pages 2471-2474.

58.     Williams JW, Javaid B, Kadambi PV, Gillen D Harland R, Thistlewaite JR, Garfinkel M,
Foster P, Atwood W, Millis JM, Meehan SM, Josephson MA Leflunomide for Polyomavirus Type BK Nephropathy. N. Engl. J. Med., March 17, 2005; 352(11):1157-1158.

59.     Poduval RD, Kadambi PV, Josephson MA, Cohn RA, Harland RC, Javaid B, Huo D,
Manaligod JR, Thistlethwaite JR, Meehan SM.  Implications of immunohistochemical detection of C4d along peritubular capillaries in last acute renal allograft rejection. Transplantation.  2005 Jan 27;79(2):227-35.

60.     Losanoff JE, Harland RC, Williams JE, Rivero OE, Reichman TW, Millis JM. Combined
kidney-pancreas transplant: early abdominal catastrophe in the donor may not be a contraindication. Transplantation, 81(8):1223 April 2006.

61.     Losanoff JE, Millis JM, Harland RC, Testa G.  Hepato-spleno-mesenteric trunk.  J Am Coll
Surg. 2007 Mar;204(3):511.  Epub 2006 Sep 26.  No abstract available.  PMID: 17324790

62.     Josephson MA, Gillen D, Javaid B, Kadambi P, Meehan S, Foster P, Harland R,
Thistlethwaite RJ, Garfinkel M, Atwood W, Jordan J, Sadhu M, Millis MJ, Williams J.
Treatment of renal allograft polyoma BK virus infection with leflunomide.  Transplantation
2006 Mar 15;81(5):704-10.

63.     Losanoff JE, Harland RC, Thistlethwaite JR, Garfinke MR, Williams, JW, Milner J, Millis JM.
Omega Jejunoduodenal Anastomosis for Pancreas Transplant.  Journal of the American College of Surgeons, Volume 202, Issue 6, June 2006, Pages 1021-1024.

64.     Orvieto MA, Chien GW, Shalhav AL, Tolhurst, SR, Rapp DE, Galocy RM, Harland RC.
Case Report:  Robot-Assisted Laparoscopic Pyeloureterostomy in a Transplant Kidney with Ureteral Stricture.  Journal of Endourology 2006 Jan, 20(1):31-32.
doi:10.1089/end.2006.20.31.

65.     Cook RI, Wreathall J, Smith A, Cronin DC, Rivero O, Harland RC, Raman J, Battles J,
Reason J.  Probabilistic Risk Assessment of Accidental ABO-Incompatible Thoracic Organ
Transplantation Before and After 2003.  Transplantation.  2007 Dec 84(12):1602-1609.

66.     Eng MK, Zorn KC, Harland RC, Bernstein AJ, Katz M, Shikanov S, Shalhav AL. Fifteen-year
follow-up of transplantation of a cadaveric polycystic kidney: a case report.  Transplantation Proceedings. 2008 Jun;40(5):1747-50.

67.     Agarwal, S, Abbo, E, Harland RC. Changes in Pediatric Renal Transplantation After
Implementation of the Revised Deceased-donor Kidney Allocation Policy. American Journal of Transplantation. 2009(9):1237-1242.

68.    
Reichman TW, Marino SR, Milner J, Harland RC, Cochrane A, Millis JM Testa G.  Acute humoral rejection in an ABO compatible combined liver-kidney transplant—the kidney is not always protected.  American Journal of Transplantation. 2009(8):1957-1960.

Abstracts (limited to the past eight years)

1.     Kim R, Nazarey P, Katz E, Callery M, Harland R, Meyers W, Chari R. Laparoscopic staging
and tumor ablation for hepatocellular carcinoma in patients with advanced cirrhosis evaluated for orthotopic liver transplantation.  American Hepato-Pancreato-Biliary Association Third Biennial Americas Congress; 22-25 February 2001; Miami Beach, FL.

2.     Banuelos SJ, Shultz LD, Harland RC, Lyons B, Rossini AA, Greiner DL, Appel MC.
Destructive infiltration of human islet allografts in hu-Pbl-NOD-SCID Mice. Transplant 2001 Annual Meeting.  May 2001, Chicago, IL.

3.     Khauli RB, Stoff JS, Fan PY, Ayvazian P, Medawar WA, Habbal A, Lovewell T, Bigwood P,
Valliere SS, Pullman JM, Blute RD, Harland R.  Chronic rejection of renal grafts:  the role of acute rejection.  Transplant Proc. 2001 Aug; 33(5):2693-4.

4.     Khauli RB, Medawar WA, Habbal AA, Birbari AE, Daouk MM, Abdelnoor AM, Uwaydah
M, Rahman Bizri A, Sanjad S, Ayvazian PJ, Lovewell T, Stoff JS, Yang Fan P, Bigwood P,
Harland R.  Improved primary transplant success rates using a triple regimen of cyclosporine
microemulsion, mycophenolate mofetil and prednisone.  Transplant Proc. 2001 Aug;
33(5):2776-7.

5.     Poduval RD, Kadambi PV, Javaid B, Meehan SM, Harland RC, Foster PF, Williams JW,
Josephson MA. Leflunomide: A potential new therapeutic agent for bk nephropathy. American Transplant Congress 2003, May 2003, Washington, DC.

6.     Khurana A, Gillen D, Baliga R, Kadambi P, Meehan S, Garfinkel M, Williams J,
Thistlethwaite JR, Harland R, Josephson M, Javaid B. Implications of lupus serologies on
graft and patient survival among renal transplant recipients (RTR) with systemic lupus
erythematosus (SLE).  American Transplant Congress 2005. May 2005, Seattle, WA.

7.     Williams J, Javaid B, Kadambi P, Foster PF, Daniel G, Meehan S, Millis JM, Harland RC,
Josephson M. The use of leflunomide in virally infected transplant patients. American Transplant Congress 2005. May 2005, Seattle, WA.

8.     Seal JB, Reichard C, Harland, RC.  Five Year Outcome of Expanded Criteria Deceased
Donor (ECD) Kidney Transplants Is Similar to Standard Criteria Deceased Donor (SCD) Kidney Transplants. American Transplant Congress 2009. Boston, MA

9.    Smith AD, Harland RC, Testa G, Gentry S. The Markov Decision Process Can Help
Maximize Benefits in Paired Kidney Donation. American Transplant Congress 2009. Boston,
MA

Book Chapters

1.     Harland RC. Delirium.  In: Lyerly HK, ed.  Handbook of Surgical Intensive Care (2nd
edition).  Chicago:Year Book Medical Publishers.  1989;503.

2.     Harland RC. Transplantation.  In: Lyerly HK, ed.    Handbook of Surgical Intensive Care (3rd
edition).  St. Louis:Year Book Medical Publishers.  1992;624.

3.    Collins BH, Harland RC. Critical care issues in organ transplantation.  In: Moylan JA, ed.
Surgical Critical Care. St. Louis:Mosby.  1994;985.

4.    Harland RC. Transplantation.  In: Sabiston DC, ed. Essentials of Surgery (2nd edition).
Saunders.  1994

5.     Harland RC. Rejection of the liver graft.  In: Killenberg PJ and Clavien PA, eds. Medical Care
of the Liver Transplant Patient.  Malden:Blackwell Science. 1997;147.

6.     Sugarman J and Harland RC. The acute, yet non-emergent patient. In: McCullough LB et al.,

eds.  Clinical Ethics in Surgery.  Oxford University Press. 1998.

7.     Thacker LR, McCune TR, and Harland RC.  Kidney Sharing by Centers of the Southeastern
Organ Procurement Foundation.  In: Cecka JM and Terasaki PI, eds. Clinical Transplants. UCLA Tissue Typing Laboratory. 1996.

8.    Harland RC. Pancreas Transplantation.  In: Norton JA et al., eds. Surgery: Basic Science and
Clinical Evidence. New York:Springer-Verlag. 2000.

9.    Harland RC. Pancreas Transplantation. In: Norton JA et al., eds. Essential Practice of
Surgery. New York:Springer-Verlag. 2002.

10.    Harland RC, Garfinkel MR. Pancreas and Islet Transplantation. In: Norton JA et al., eds. Surgery: Basic Science and Clinical Evidence (second edition). New York:Springer-Verlag. 2008.